Democrats, Energy and Commerce Committee

TSCASigning_2.png

Pallone Praises President Obama for Signing TSCA Reform

President Obama signs into law H.R. 2576, the Frank R. Lautenberg Chemical Safety for the 21st Century Act, which modernizes the Toxic Substances Control Act. Read More
Screen Shot 2016-05-23 at 11.35.40 AM.png

Democratic Committee Investigation Finds NFL Improperly Attempted to Influence NIH on Brain Injury Research

The NFL inappropriately attempted to influence independent research by the NIH on sports-related brain injuries, an investigation conducted by E&C Democratic Committee staff has found.. Read More
IMG_2530.jpg

Watch Hearing on "Deciphering the Debate Over Encryption"

The Oversight & Investigations subcommittee held a hearing examining industry and law enforcement perspectives on the debate over encryption. Read More
IMG_1102.jpg

E&C Dem Leaders Urge NFL to Act After Acknowledgement of Risks Posed by Repetitive Brain Trauma

Democratic leaders of the Energy and Commerce Committee have sent a letter to NFL Commissioner Roger Goodell asking what the League plans to do to prevent repetitive brain trauma. Read More

Latest News

Bipartisan Leaders Work Toward Successful Implementation of MACRA

Sep 6, 2016 Press Release

Energy & Commerce and Ways & Means Leaders Urge HHS Secretary Burwell to Consider Flexibilities for All Practitioners

Bipartisan leaders from the House Energy and Commerce Committee and the House Ways and Means Committee today sent a

Issues:

Health

Cantwell, Pallone Urge Senate Passage of SANDy Act to Secure Communications During Weather Emergencies

Sep 2, 2016 Press Release

With a hurricane and tropical storms hitting both the East Coast and Hawaii this week, Senator Maria Cantwell (D-WA), a senior member of the Senate Commerce, Science and Transportation Committee, and Congressman Frank Pallone, Jr.

Issues:

Communications and Technology

Wyden, Pallone Question Mylan Payments to Medicaid for EpiPens

Sep 2, 2016 Press Release

Due to Apparent Decades-Long Misclassification as a Generic Drug, EpiPen Manufacturer Could Have Received Substantially More Taxpayer Dollars than Law Allows

Issues:

Health